VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $17,142,000 | +68.4% | 737,618 | +15.3% | 0.05% | +64.3% |
| Q1 2018 | $10,181,000 | -65.7% | 639,518 | -55.2% | 0.03% | -65.0% |
| Q4 2017 | $29,683,000 | +10615.9% | 1,428,418 | +7294.2% | 0.08% | +7900.0% |
| Q3 2017 | $277,000 | -96.3% | 19,318 | -95.6% | 0.00% | -96.0% |
| Q2 2017 | $7,583,000 | +489.2% | 438,338 | +275.7% | 0.02% | +525.0% |
| Q1 2017 | $1,287,000 | -95.5% | 116,664 | -94.1% | 0.00% | -96.4% |
| Q4 2016 | $28,864,000 | +530.8% | 1,987,851 | +774.8% | 0.11% | +378.3% |
| Q2 2016 | $4,576,000 | +341.3% | 227,231 | +3809.0% | 0.02% | +228.6% |
| Q3 2015 | $1,037,000 | -77.4% | 5,813 | -71.9% | 0.01% | -80.0% |
| Q2 2015 | $4,590,000 | +808.9% | 20,672 | +485.4% | 0.04% | +775.0% |
| Q4 2014 | $505,000 | -81.9% | 3,531 | -83.4% | 0.00% | -81.8% |
| Q3 2014 | $2,786,000 | -91.9% | 21,231 | -92.3% | 0.02% | -91.9% |
| Q2 2014 | $34,586,000 | +13.7% | 274,231 | +18.9% | 0.27% | -2.5% |
| Q1 2014 | $30,418,000 | +233.1% | 230,731 | +163.6% | 0.28% | +154.1% |
| Q3 2013 | $9,131,000 | – | 87,531 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |